Evidence map›Paper›PMID 35052271›Full record

ArticleHealthcare (Basel, Switzerland)2022

Burden of Chronic Heart Failure in Romania.

László Lorenzovici, Andrea Bârzan-Székely, Szabolcs Farkas-Ráduly, Bogdan C Pană, Marcell Csanádi, Nona Delia Chiriac, Zoltán Kaló

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

László LorenzoviciSyreon Research Romania, 540004 Tirgu Mures, Romania.ORCID 0000-0002-1817-2674
Andrea Bârzan-SzékelySyreon Research Romania, 540004 Tirgu Mures, Romania.ORCID 0000-0002-5365-2833
Szabolcs Farkas-RádulySyreon Research Romania, 540004 Tirgu Mures, Romania.
Bogdan C PanăDepartment of Public Health, University of Medicine and Pharmacy "Carol Davila" Bucharest, 020021 Bucharest, Romania.
Marcell CsanádiSyreon Research Institute, 1142 Budapest, Hungary.ORCID 0000-0002-5724-639X
Nona Delia ChiriacNovartis Pharma Services, 020334 Bucharest, Romania.
Zoltán KalóSyreon Research Institute, 1142 Budapest, Hungary.ORCID 0000-0001-7762-2607
Carol Davila University of Medicine and Pharmacy · ROSemmelweis University · HUSyreon Research Institute (Hungary) · HUUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · RO

Funding

Novartis Pharma Services Romania SRL 20202878/18.12.2020
6 · The paper itself

Abstract

Chronic heart failure (CHF) affects millions of people across the world, with increasing trends in prevalence, putting ever increasing pressure on the healthcare system. The aim of this study was to assess the financial burden of CHF hospital care on the public healthcare sector in Romania by estimating the number of inpatient episodes and the associated costs. Additionally, societal costs associated with missed work and premature death of CHF patients were also estimated. The national claims database was analyzed to estimate the number of CHF patients. Cost data was extracted from a pool of nine public hospitals in Romania. In 2019, 375,037 CHF patient episodes were identified on specific wards at the national level. The average cost calculated for the selected nine hospitals was EUR 996. The calculated weighted national average cost per patient episode was EUR 1002, resulting in a total cost of EUR 376 million at the national level. The cost of workdays missed summed up to EUR 122 million, while the annual costs associated with the premature death of CHF patients was EUR 230 million. In conclusion, the prevalence of CHF in Romania is high, accounting for a large proportion of hospitalizations, which translates into large costs for the national payer.

Indexed as

burden of diseaseCHFchronic heart failurecost of hospitalizationRomania

Identifiers

PMID35052271
PMCPMC8775306
OpenAlexW4206627427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.